A groundbreaking study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC).
New research published in Arthritis & Rheumatology suggests that for people overweight or with obesity who also have knee or hip osteoarthritis, a slow-to-moderate—but not fast—rate of weight loss caused by anti-obesity medications may lower their risk of premature death.
A Cleveland Clinic study looked at the long-term use of anti-obesity medications and found that only 19% of the study participants continued to use the medications one year after their initial prescriptions.
People in Sweden of non-European descent have almost three times as many eating disorder symptoms as people born in Sweden. But despite this, they have significantly less access to specialist treatment. This is according to new research from Karolinska Institutet published in BJPsych Open.
Vanderbilt University Medical Center has received a $10 million, five-year research funding award from the Patient-Centered Outcomes Research Institute (PCORI) to study the ideal “dose” of behavioral interventions to treat childhood obesity in rural and minority communities across Tennessee and Louisiana. Bill Heerman, MD, MPH, chief of the Division of General Pediatrics a Vanderbilt, will lead the randomized, multisite trial with co-principal investigator Amanda Staiano, PhD, at Louisiana State University’s Pennington Biomedical Research Center.
There’s a popular saying in some circles that “a calorie is a calorie,” but science shows that it may not be true. In fact, it may be possible to eat more of some kinds of calories while also improving your health.“We like to say a calorie is not just a calorie,” says Dudley Lamming, a professor and metabolism researcher at the University of Wisconsin School of Medicine and Public Health.
Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.
Not for public release
This news release is embargoed until 20-Nov-2023 5:00 PM EST
Released to reporters: 14-Nov-2023 2:00 PM EST
A reporter's PressPass is required to
access this story until the embargo expires on 20-Nov-2023 5:00 PM EST
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
A new study from the University of Illinois Urbana-Champaign investigates how high obesity levels lead to hospital specializations that affect the frequency of C-sections in Mexico.
The world’s total population is expected to reach 9.9 billion by 2050. This rapid increase in population is boosting the demand for agriculture to cater for the increased demand. Below are some of the latest research and features on agriculture and farming in the Agriculture channel on Newswise.
By: Bill Wellock | Published: November 14, 2023 | 2:43 pm | SHARE: The U.S. Food and Drug Administration recently approved the medication Zepbound for weight management treatment.Tirzepatide, the active ingredient in the Eli Lilly and Company’s trademarked Zepbound, was already approved to help improve blood sugar (glucose) in adults with type 2 diabetes mellitus.
Expressing outrage over the state’s plan to kill programs well-proven to slash diabetes and other chronic disease, activists, providers and patients rallied outside the state Health Department in lower Manhattan today, World Diabetes Day, to protest state negligence that will clearly impose even worse chronic disease on low-income communities already reeling from the aftermath of Covid-19.
Researchers led by Mroj Alassaf at the Fred Hutchinson Cancer Research Center in the United States have discovered a link between obesity and neurodegenerative disorders like Alzheimer’s disease.
In what is believed to be the largest study of the association between BMI and postoperative complications following chest masculinization surgery, researchers at the Johns Hopkins Center for Transgender and Gender Expansive Health provide evidence that BMI is a poor metric for determining who should be approved for the gender transitioning procedure.
Not for public release
This news release is embargoed until 6-Nov-2023 5:00 PM EST
Released to reporters: 31-Oct-2023 2:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 6-Nov-2023 5:00 PM EST
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Beep test or shuttle run - we all remember fitness time trials in school. But did you know that your early experiences of compulsory fitness may have influenced your current views of physical exercise (PE)?
Feline obesity is on the rise, impacting the health, longevity, and wellbeing of cats. A new study from the University of Illinois Urbana-Champaign looks at what happens in the digestive system and gut microbiota when cats eat too much.
Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist, the academic core of Advocate Health, are launching their largest campaign for research. Designed with health equity at the forefront, funds raised in this campaign will transform health care for patients, communities and the next generation of health care leaders by integrating research with clinical care while enhancing the speed with which new ideas move from research labs to patients' bedsides and beyond.
Angina, chest discomfort caused by reduced blood flow to the heart, is a common symptom of coronary artery disease. There is good news and bad news, explains Stephen Brecker, M.D., a cardiologist at Mayo Clinic Healthcare in London.
Current osteoarthritis treatment manages symptoms rather than addressing the underlying disease, but a new University of Adelaide study has shown the condition may be treatable and reversible.
A new large-scale study led by researchers at the University of Cincinnati and Northwell Health, New York's largest health care provider, found the drug metformin can help prevent or reduce weight gain in youth taking medication to treat bipolar disorder.
Researchers at Indiana University School of Medicine will play key roles in a national consortium led by Wake Forest University School of Medicine to study the use, interpretation and implementation of biomarkers to diagnose Alzheimer's disease. The multi-institution effort is funded by a five-year, $9 million grant from the National Institute on Aging, part of the National Institutes of Health, that will establish the Alzheimer's Diagnosis in Older Adults with Chronic Conditions (ADACC) Network.
A sweeping new guide to menopause by a UVA Health expert and collaborators highlights the profound and sometimes surprising effects the “change of life” can have on women’s lives, health, workplaces and even finances
Endocrine Society experts will discuss how these medications and bariatric surgery can treat obesity and improve cardiometabolic health, during the Society’s Virtual Science Writers Conference on November 9.
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are successful in treating type 2 diabetes mellitus and obesity. However, their use can increase the risk of regurgitation and pulmonary aspiration of gastric contents during sedation or general anesthesia. In the January 2024 issue of Anesthesia & Analgesia, Girish P. Joshi, MBBS, MD, FFARCSI, Professor of Anesthesiology and Pain Management at the University of Texas Southwestern Medical Center in Dallas, shares clinical pearls for anesthesiologists providing perioperative care to patients using these drugs. Anesthesia & Analgesia, the official journal of the International Anesthesia Research Society, is published in the Lippincott portfolio by Wolters Kluwer.
Findings from 50 years of data highlighted the health risks when more weight is gained in pregnancy than recommended, especially when it comes to heart disease- and diabetes-related mortality
In a first-of-its-kind study, researchers from the University of California, Irvine have discovered an extraordinary surge in the utilization of weight loss-associated GLP-1 receptor agonists, a class of medications commonly used in the treatment of Type 2 diabetes and obesity, that is poised to accelerate, based on emerging clinical evidence.
Children fall broadly into four eating categories, according to new research at Aston University, and parents feed their children differently depending on those categories.
SEATTLE – OCTOBER 17, 2023 – Fred Hutchinson Cancer Center has announced the recipients of the 2023 Dr. Eddie Méndez Scholar Award, which recognizes early-career underrepresented minority scientists and scientists with disabilities.
Scientists from Immanuel Kant Baltic Federal University on the base of literary sources have described in detail the connection between intracellular processes in mitochondria and metabolic disorders in human’s organism that lead to obesity and cardiovascular diseases.
A new Journal of the Endocrine Society study highlights how to identify children at high risk of developing type 2 diabetes and strategies for prevention, such as anti-obesity or anti-diabetes medication and lifestyle changes.
Pregnancy complications such as preeclampsia and gestational diabetes have recently been associated with a higher risk of developing heart disease later in life. But a new Northwestern Medicine study has found obesity before or during pregnancy is the actual root cause of future cardiovascular disease.
Improving insulin resistance with metformin, a medication used to treat Type 2 diabetes, reduced the chances of developing kidney disease in a prepubescent obese rat model, according to a new study from the University of Mississippi Medical Center.
Health experts are redefining cardiovascular disease (CVD) risk, prevention and management, according to a new American Heart Association presidential advisory published today in the Association’s flagship journal Circulation.
These drugs are not the be-all and end-all to weight-loss therapy, wrote Dr. Michael Schwartz in a commentary published Oct. 2 in The Journal of Clinical Investigation. His co-author was Sophie Yang Gou, a postdoctoral fellow in Schwartz’s lab at the University of Washington School of Medicine.
Many experts seem to be saying “OK, we’ve fixed this problem. We’re done,” noted Schwartz, who co-directs the UW Medicine Diabetes Institute. That is simply not the case, he said.
A UCLA-led team of researchers has found nerve pathways that supply brown adipose tissue (BAT), a type of tissue that releases chemical energy from fat metabolism as heat – a finding that could pave the way toward using it to treat obesity and related metabolic conditions.
A researcher at The University of Alabama in Huntsville (UAH) has been awarded a $179,000 subcontract to explore community-based strategies for reducing high-burden chronic disease like obesity, diabetes, heart disease and cancer as part of an overall award totaling $4.2 million.
People frequently exposed to racial or ethnic discrimination may be more susceptible to obesity and related health risks in part because of a stress response that changes biological processes and how we process food cues according to UCLA research.
Not for public release
This news release is embargoed until 28-Sep-2023 2:00 PM EDT
Released to reporters: 26-Sep-2023 4:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 28-Sep-2023 2:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.